Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase.

MLA

Jingkun Zeng, et al. “Identifying SARS-CoV-2 Antiviral Compounds by Screening for Small Molecule Inhibitors of Nsp13 Helicase.” Biochemical Journal, vol. 478, no. 13, July 2021, pp. 2405–23. EBSCOhost, https://doi.org/10.1042/BCJ20210201.

APA

Jingkun Zeng, Weissmann, F., Bertolin, A. P., Posse, V., Canal, B., Ulferts, R., Wu, M., Harvey, R., Hussain, S., Milligan, J. C., Roustan, C., Borg, A., McCoy, L., Drury, L. S., Kjaer, S., McCauley, J., Howell, M., Beale, R., & Diffley, J. F. X. (2021). Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase. Biochemical Journal, 478(13), 2405–2423. https://doi.org/10.1042/BCJ20210201

Chicago

Jingkun Zeng, Florian Weissmann, Agustina P. Bertolin, Viktor Posse, Berta Canal, Rachel Ulferts, Mary Wu, et al. 2021. “Identifying SARS-CoV-2 Antiviral Compounds by Screening for Small Molecule Inhibitors of Nsp13 Helicase.” Biochemical Journal 478 (13): 2405–23. doi:10.1042/BCJ20210201.